With human consortia, Illumina helps biomedical researchers from across the world work together to design and run custom genomics assays. Illumina coordinates, members pool resources, and everyone benefits.
Consortia products include high-powered genotyping arrays and other next-generation genetic analysis tools. Human consortia may be open or confidential. From custom content to project management and bioinformatics, Illumina offers a comprehensive solution for human consortia members. The following are our currently open human consortia offerings.
The H3Africa Consortium seeks to empower researchers with leading-edge genomics tools to study environmental and genetic factors that play a role in disease susceptibility and drug responses. With novel, genome-wide content from individuals across African populations, and built on the MEGA Array backbone, the H3Africa Consortium Array1 is designed to be an effective and comprehensive array for the study of African Genomics. H3Africa data will inform strategies to address health inequity and will lead to health benefits in Africa and beyond.
A powerful array for genetic studies focused on African populations.
Read Data SheetInterested in joining an existing human disease research consortium or starting a new one? Contact us.
Explore sequencing- and array-based genotyping solutions that can provide insight into the functional consequences of genetic variation.
Learn MoreThis genotyping array was developed in collaboration with leaders in translational genomics and computational biology. It enables researchers to more effectively screen potential drug targets earlier in the development process. Learn more about this consortium.
Partners from the neurogenomics community designed the Neuro Consortium Array to interrogate the genomics of neurodegenerative diseases. The consortium gathered all identified markers found in known neurodegenerative disease genes, to include in a single array.
The Neuro Consortium Array is now available with updated content as the Neuro Booster. Learn more about this consortium.